Abstract
Angiogenesis, the formation of new blood vessels, is seen during embryonic development and tumor progression, but the mechanisms have remained unclear. Recent data indicate that tumor angiogenesis can be induced by cellular oncogenes, leading to the enhanced activity of molecules stimulating angiogenesis. However, activated oncogenes might also facilitate angiogenesis by down-regulating endogenous inhibitors of angiogenesis. We report here that enhanced expression of the N-myc oncogene in human neuroblastoma cells down-regulates three inhibitors of endothelial cell proliferation. One of them was identified by amino acid sequencing as being identical with activin A, a developmentally-regulated protein. Down-regulation involves interaction of the N-myc protein with the activin A promoter. Work is ongoing to characterize the other two endothelial cell inhibitors. We suggest that the N-myc induced down-regulation of angiogenesis inhibitors could contribute to tumor angiogenesis.
*
These authors contributed equally to this work.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Klagsbrun, M. & Folkman, J. (1990) Angiogenesis. In Peptide growth factors and their receptors II (Sporn, M.B., & Roberts A.B., eds), pp. 549–586. Springer Verlag, Berlin.
Folkman, J. & Cotran, R.S. (1976) Relation of vascular proliferation to tumor growth. Int. Rev. Exp. Pathol., 16, 207–248.
Hanahan, D. & Folkman, J. (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell, 86, 353–364.
Folkman, J. (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Medicine, 1, 27–31.
Liotta, L.A., Steeg, P.S. & Stetler-Stevenson, W.G. (1991) Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell, 64, 327–336.
Vogelstein, B. & Kinzler, K.W. (1993) The multistep nature of cancer. Trends Genet, 9, 138–141.
Bishop, J.M. (1987) The molecular genetics of cancer. Science, 235, 305–311.
Dameron, K.M., Volpert, O.V., Tainsky, M.A. & Bouck, N. (1994) Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science, 265, 1582–1584.
Volpert, O.V., Stellmach, V. & Bouck, N. (1996) The modulation of thrompospondin and other naturally occuring inhibitors of angiogenesis during tumor progression. Breast Cancer Res. Treat, 36, 119–126.
Van Meir, E.G., Polverini, P.J., Chazin, V.R., Su Huang, H.-J., De Tribolet N. & Cavenee, W.K. (1994) Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells. Nature Genet, 8, 171–176.
Bouck, N., Stellmach, V. & Hsu, S.C. (1996) How tumors become angiogenic. Adv. Cancer Res., 69, 135–174.
Brodeur, G.M., Seeger, R.C., Schwab, M., Varmus, H.E. & Bishop, J.M. (1984) Amplification of MYCN in untreated human neuroblastomas correlates with advanced disease stage. Science, 224, 1121–1124.
Grady-Leopardi, E., Schwab, M., Ablin, A. & Rosenau, W. (1986) Detection of NMYC oncogene expression in human neuroblastoma by in situ hybridization and blot analysis: Relationship to clinical outcome. Cancer Res., 46, 3196–3199.
Meitar, D., Crawford, S.E., Radmaker, A.W. & Cohn, S.L. (1996) Tumor angiogenesis correlates with metastatic disease, N-myc amplification, and poor outcome in human neuroblastoma. J. Clin. Oncol., 14, 405–414.
Schweigerer, L., Breit, S., Wenzel, A., Tsunamoto, K., Ludwig, R. & Schwab, M. (1990) Augmented MYCN expression advances the malignant phenotype of human neuroblastoma cells: Evidence for induction of autocrine growth activity. Cancer Res., 50, 4411–4416.
Fotsis, T., Breit, S., Lutz, W., Rössler, J., Hatzi, E., Schwab, M., & Schweigerer, L. (1999) Down-regulation of endothelial cell growth inhibitors by enhanced MYCN oncogene expression in human neuroblastoma cells. Eur. J. Biochem. (in press).
Tanimoto, K., Yoshida, E., Mita, S., Nibu, Y., & Fukamizu, A. (1996) Human activin A gene. J. Biol. Chem., 271, 32760–32769.
Wenzel, A., Csiepluch, C, Hamann, U., Schürmann, J., & Schwab, M. (1991) The N-myc oncoprotein is associated in vivo with the phosphoprotein Max (p20/22) in human neuroblastoma cells. EMBO J., 10, 3703–3712.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer Science+Business Media New York
About this chapter
Cite this chapter
Hatzi, E. et al. (2000). MYCN Oncogene and Angiogenesis: Down-Regulation of Endothelial Growth Inhibitors in Human Neuroblastoma Cells. In: Maragoudakis, M.E. (eds) Angiogenesis. Advances in Experimental Medicine and Biology, vol 476. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4221-6_19
Download citation
DOI: https://doi.org/10.1007/978-1-4615-4221-6_19
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6895-3
Online ISBN: 978-1-4615-4221-6
eBook Packages: Springer Book Archive